# Itron, Inc.: financial statements, quarterly

ITRI · Nasdaq · CIK 780571 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/itri.md) · [Financials](/companies/itri/financials.md) · [Filings](/companies/itri/filings.md) · [Insiders](/companies/itri/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/itri/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [577 d](/filings/0000780571-26-000033.md) | [603](/filings/0000780571-25-000015.md) | [609](/filings/0000780571-25-000036.md) | [615](/filings/0000780571-25-000074.md) | [613 d](/filings/0000780571-26-000033.md) | [607](/filings/0000780571-26-000110.md) | [607](/filings/0000780571-26-000178.md) | [582](/filings/0000780571-26-000233.md) | [572 d](/filings/0000780571-26-000033.md) | [587](/filings/0000780571-26-000110.md) | [563](/filings/0000780571-26-000178.md) | [599](/filings/0000780571-26-000233.md) |
| Cost of revenue | $m | [381 d](/filings/0000780571-26-000033.md) | [398](/filings/0000780571-25-000015.md) | [399](/filings/0000780571-25-000036.md) | [406](/filings/0000780571-25-000074.md) | [399 d](/filings/0000780571-26-000033.md) | [390](/filings/0000780571-26-000110.md) | [383](/filings/0000780571-26-000178.md) | [362](/filings/0000780571-26-000233.md) | [340 d](/filings/0000780571-26-000033.md) | [351](/filings/0000780571-26-000110.md) | [332](/filings/0000780571-26-000178.md) | [354](/filings/0000780571-26-000233.md) |
| Gross profit | $m | [196 d](/filings/0000780571-26-000033.md) | [205](/filings/0000780571-25-000015.md) | [210](/filings/0000780571-25-000036.md) | [210](/filings/0000780571-25-000074.md) | [214 d](/filings/0000780571-26-000033.md) | [217](/filings/0000780571-26-000110.md) | [224](/filings/0000780571-26-000178.md) | [220](/filings/0000780571-26-000233.md) | [232 d](/filings/0000780571-26-000033.md) | [236](/filings/0000780571-26-000110.md) | [231](/filings/0000780571-26-000178.md) | [245](/filings/0000780571-26-000233.md) |
| Research and development | $m | [53.9 d](/filings/0000780571-26-000033.md) | [52.4](/filings/0000780571-25-000015.md) | [53.1](/filings/0000780571-25-000036.md) | [51.2](/filings/0000780571-25-000074.md) | [58.3 d](/filings/0000780571-26-000033.md) | [50.1](/filings/0000780571-26-000110.md) | [53.8](/filings/0000780571-26-000178.md) | [50.0](/filings/0000780571-26-000233.md) | [53.1 d](/filings/0000780571-26-000033.md) | [55.0](/filings/0000780571-26-000110.md) | [56.1](/filings/0000780571-26-000178.md) | [57.0](/filings/0000780571-26-000233.md) |
| Selling, general and administrative | $m | [81.6 d](/filings/0000780571-26-000033.md) | [86.0](/filings/0000780571-25-000015.md) | [88.4](/filings/0000780571-25-000036.md) | [79.6](/filings/0000780571-25-000074.md) | [85.0 d](/filings/0000780571-26-000033.md) | [86.9](/filings/0000780571-26-000110.md) | [87.6](/filings/0000780571-26-000178.md) | [83.1](/filings/0000780571-26-000233.md) | [95.3 d](/filings/0000780571-26-000033.md) | [105](/filings/0000780571-26-000110.md) | [89.7](/filings/0000780571-26-000178.md) | [84.1](/filings/0000780571-26-000233.md) |
| Operating income | $m | [49.3 d](/filings/0000780571-26-000033.md) | [62.8](/filings/0000780571-25-000015.md) | [64.6](/filings/0000780571-25-000036.md) | [73.9](/filings/0000780571-25-000074.md) | [62.7 d](/filings/0000780571-26-000033.md) | [76.2](/filings/0000780571-26-000110.md) | [76.4](/filings/0000780571-26-000178.md) | [81.8](/filings/0000780571-26-000233.md) | [78.7 d](/filings/0000780571-26-000033.md) | [67.6](/filings/0000780571-26-000110.md) | [76.1](/filings/0000780571-26-000178.md) | [95.5](/filings/0000780571-26-000233.md) |
| Interest expense | $m | [1.9 d](/filings/0000780571-24-000006.md) | [1.9](/filings/0000780571-24-000010.md) | [2.3](/filings/0000780571-24-000043.md) | [5.6](/filings/0000780571-24-000048.md) | [5.6 d](/filings/0000780571-26-000033.md) | [5.6](/filings/0000780571-26-000110.md) | [5.6](/filings/0000780571-26-000178.md) | [5.6](/filings/0000780571-26-000233.md) | [5.6 d](/filings/0000780571-26-000033.md) | [5.8](/filings/0000780571-26-000110.md) | [5.8](/filings/0000780571-26-000178.md) | [5.9](/filings/0000780571-26-000233.md) |
| Income tax | $m | [4.6 d](/filings/0000780571-26-000033.md) | [13.4](/filings/0000780571-25-000015.md) | [15.2](/filings/0000780571-25-000036.md) | [3.5](/filings/0000780571-25-000074.md) | [11.3 d](/filings/0000780571-26-000033.md) | [16.9](/filings/0000780571-26-000110.md) | [14.7](/filings/0000780571-26-000178.md) | [24.5](/filings/0000780571-26-000233.md) | [(17.2) d](/filings/0000780571-26-000033.md) | [13.6](/filings/0000780571-26-000110.md) | [26.7](/filings/0000780571-26-000178.md) | [25.8](/filings/0000780571-26-000233.md) |
| Net income | $m | [44.4 d](/filings/0000780571-26-000033.md) | [51.7](/filings/0000780571-25-000015.md) | [51.3](/filings/0000780571-25-000036.md) | [78.0](/filings/0000780571-25-000074.md) | [58.1 d](/filings/0000780571-26-000033.md) | [65.5](/filings/0000780571-26-000110.md) | [68.3](/filings/0000780571-26-000178.md) | [65.6](/filings/0000780571-26-000233.md) | [102 d](/filings/0000780571-26-000033.md) | [53.5](/filings/0000780571-26-000110.md) | [53.3](/filings/0000780571-26-000178.md) | [71.4](/filings/0000780571-26-000233.md) |
| Diluted EPS | $ per share | not reported | [1.12](/filings/0000780571-25-000015.md) | [1.10](/filings/0000780571-25-000036.md) | [1.70](/filings/0000780571-25-000074.md) | not reported | [1.42](/filings/0000780571-26-000110.md) | [1.47](/filings/0000780571-26-000178.md) | [1.41](/filings/0000780571-26-000233.md) | not reported | [1.18](/filings/0000780571-26-000110.md) | [1.19](/filings/0000780571-26-000178.md) | [1.61](/filings/0000780571-26-000233.md) |
| Basic EPS | $ per share | not reported | [1.13](/filings/0000780571-25-000015.md) | [1.12](/filings/0000780571-25-000036.md) | [1.73](/filings/0000780571-25-000074.md) | not reported | [1.44](/filings/0000780571-26-000110.md) | [1.50](/filings/0000780571-26-000178.md) | [1.43](/filings/0000780571-26-000233.md) | not reported | [1.20](/filings/0000780571-26-000110.md) | [1.21](/filings/0000780571-26-000178.md) | [1.63](/filings/0000780571-26-000233.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [302](/filings/0000780571-25-000007.md) | [301](/filings/0000780571-24-000010.md) | [921](/filings/0000780571-24-000043.md) | [983](/filings/0000780571-24-000048.md) | [1,051](/filings/0000780571-26-000033.md) | [1,123](/filings/0000780571-25-000015.md) | [1,224](/filings/0000780571-25-000036.md) | [1,332](/filings/0000780571-25-000074.md) | [1,020](/filings/0000780571-26-000233.md) | [713](/filings/0000780571-26-000110.md) | [745](/filings/0000780571-26-000178.md) | [840](/filings/0000780571-26-000233.md) |
| Current assets | $m | [1,049](/filings/0000780571-25-000007.md) | [1,097](/filings/0000780571-24-000010.md) | [1,689](/filings/0000780571-24-000043.md) | [1,755](/filings/0000780571-24-000048.md) | [1,816](/filings/0000780571-26-000033.md) | [1,903](/filings/0000780571-25-000015.md) | [1,989](/filings/0000780571-25-000036.md) | [2,144](/filings/0000780571-25-000074.md) | [1,822](/filings/0000780571-26-000233.md) | [1,525](/filings/0000780571-26-000110.md) | [1,550](/filings/0000780571-26-000178.md) | [1,684](/filings/0000780571-26-000233.md) |
| Total assets | $m | [2,604](/filings/0000780571-25-000007.md) | [2,677](/filings/0000780571-24-000010.md) | [3,284](/filings/0000780571-24-000043.md) | [3,365](/filings/0000780571-24-000048.md) | [3,408](/filings/0000780571-26-000033.md) | [3,503](/filings/0000780571-25-000015.md) | [3,624](/filings/0000780571-25-000036.md) | [3,711](/filings/0000780571-25-000074.md) | [3,721](/filings/0000780571-26-000233.md) | [3,978](/filings/0000780571-26-000110.md) | [3,994](/filings/0000780571-26-000178.md) | [4,117](/filings/0000780571-26-000233.md) |
| Current liabilities | $m | [537](/filings/0000780571-25-000007.md) | [578](/filings/0000780571-24-000010.md) | [535](/filings/0000780571-24-000043.md) | [521](/filings/0000780571-24-000048.md) | [528](/filings/0000780571-26-000033.md) | [983](/filings/0000780571-25-000015.md) | [973](/filings/0000780571-25-000036.md) | [987](/filings/0000780571-25-000074.md) | [1,012](/filings/0000780571-26-000233.md) | [574](/filings/0000780571-26-000110.md) | [564](/filings/0000780571-26-000178.md) | [596](/filings/0000780571-26-000233.md) |
| Total liabilities | $m | [1,273](/filings/0000780571-25-000007.md) | [1,291](/filings/0000780571-24-000010.md) | [2,023](/filings/0000780571-24-000043.md) | [1,997](/filings/0000780571-24-000048.md) | [1,996](/filings/0000780571-26-000033.md) | [1,994](/filings/0000780571-25-000015.md) | [1,989](/filings/0000780571-25-000036.md) | [1,997](/filings/0000780571-25-000074.md) | [1,983](/filings/0000780571-26-000233.md) | [2,349](/filings/0000780571-26-000110.md) | [2,355](/filings/0000780571-26-000178.md) | [2,398](/filings/0000780571-26-000233.md) |
| Long-term debt | $m | [455](/filings/0000780571-25-000007.md) | [455](/filings/0000780571-24-000010.md) | [1,240](/filings/0000780571-24-000043.md) | [1,241](/filings/0000780571-24-000048.md) | [1,242](/filings/0000780571-26-000033.md) | [786](/filings/0000780571-25-000015.md) | [787](/filings/0000780571-25-000036.md) | [788](/filings/0000780571-25-000074.md) | [789](/filings/0000780571-26-000233.md) | [1,574](/filings/0000780571-26-000110.md) | [1,575](/filings/0000780571-26-000178.md) | [1,577](/filings/0000780571-26-000233.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0000780571-26-000033.md) | [458](/filings/0000780571-25-000015.md) | [458](/filings/0000780571-25-000036.md) | [459](/filings/0000780571-25-000074.md) | [460](/filings/0000780571-26-000233.md) | [0.0](/filings/0000780571-26-000110.md) | [0.0](/filings/0000780571-26-000178.md) | [0.0](/filings/0000780571-26-000233.md) |
| Shareholders' equity | $m | [1,311](/filings/0000780571-25-000007.md) | [1,365](/filings/0000780571-24-000010.md) | [1,240](/filings/0000780571-24-000043.md) | [1,348](/filings/0000780571-24-000048.md) | [1,391](/filings/0000780571-26-000033.md) | [1,488](/filings/0000780571-25-000015.md) | [1,613](/filings/0000780571-25-000036.md) | [1,693](/filings/0000780571-25-000074.md) | [1,717](/filings/0000780571-26-000233.md) | [1,607](/filings/0000780571-26-000110.md) | [1,616](/filings/0000780571-26-000178.md) | [1,699](/filings/0000780571-26-000233.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [47.9 d](/filings/0000780571-26-000033.md) | [41.3](/filings/0000780571-25-000015.md) | [51.7 d](/filings/0000780571-25-000036.md) | [65.3 d](/filings/0000780571-25-000074.md) | [79.8 d](/filings/0000780571-26-000033.md) | [72.1](/filings/0000780571-26-000110.md) | [96.7 d](/filings/0000780571-26-000178.md) | [118 d](/filings/0000780571-26-000233.md) | [119 d](/filings/0000780571-26-000033.md) | [85.5](/filings/0000780571-26-000110.md) | [88.1 d](/filings/0000780571-26-000178.md) | [102 d](/filings/0000780571-26-000233.md) |
| Capital expenditure | $m | [8.6 d](/filings/0000780571-26-000033.md) | [7.1](/filings/0000780571-25-000015.md) | [7.1 d](/filings/0000780571-25-000036.md) | [6.6 d](/filings/0000780571-25-000074.md) | [9.7 d](/filings/0000780571-26-000033.md) | [4.6](/filings/0000780571-26-000110.md) | [6.0 d](/filings/0000780571-26-000178.md) | [4.4 d](/filings/0000780571-26-000233.md) | [7.8 d](/filings/0000780571-26-000033.md) | [6.5](/filings/0000780571-26-000110.md) | [6.6 d](/filings/0000780571-26-000178.md) | [6.4 d](/filings/0000780571-26-000233.md) |
| Share repurchases | $m | [0.0 d](/filings/0000780571-26-000033.md) | not reported | not reported | [0.0 d](/filings/0000780571-25-000074.md) | [0.0 d](/filings/0000780571-26-000033.md) | [0.0](/filings/0000780571-26-000110.md) | [0.0 d](/filings/0000780571-26-000178.md) | [0.0 d](/filings/0000780571-26-000233.md) | [100 d](/filings/0000780571-26-000033.md) | [100](/filings/0000780571-26-000110.md) | [52.2 d](/filings/0000780571-26-000178.md) | [0.0 d](/filings/0000780571-26-000233.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [45.3](/filings/0000780571-24-000010.md) | [45.8](/filings/0000780571-24-000043.md) | [46.0](/filings/0000780571-24-000048.md) | [46.4](/filings/0000780571-25-000015.md) | [46.5](/filings/0000780571-25-000036.md) | [45.8](/filings/0000780571-25-000074.md) | [46.2](/filings/0000780571-26-000110.md) | [46.4](/filings/0000780571-26-000178.md) | [46.7](/filings/0000780571-26-000233.md) | [45.5](/filings/0000780571-26-000110.md) | [44.6](/filings/0000780571-26-000178.md) | [44.4](/filings/0000780571-26-000233.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 43,860,429 at 2026-10-23, from the cover of the [10-Q filed 2026-10-27](/filings/0000780571-26-000233.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 12:53 ET. No prices; not investment advice.